INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $158,000 | +9.0% | 7,341 | 0.0% | 0.01% | -68.6% |
| Q2 2022 | $145,000 | -16.2% | 7,341 | 0.0% | 0.04% | +6.1% |
| Q1 2022 | $173,000 | -13.5% | 7,341 | 0.0% | 0.03% | -2.9% |
| Q4 2021 | $200,000 | -7.0% | 7,341 | -6.0% | 0.03% | -10.5% |
| Q3 2021 | $215,000 | -3.2% | 7,813 | 0.0% | 0.04% | +8.6% |
| Q2 2021 | $222,000 | -16.5% | 7,813 | 0.0% | 0.04% | -22.2% |
| Q1 2021 | $266,000 | +2.3% | 7,813 | 0.0% | 0.04% | +2.3% |
| Q4 2020 | $260,000 | +3.6% | 7,813 | 0.0% | 0.04% | -6.4% |
| Q3 2020 | $251,000 | +16.7% | 7,813 | 0.0% | 0.05% | +20.5% |
| Q2 2020 | $215,000 | +156.0% | 7,813 | +48.3% | 0.04% | +116.7% |
| Q1 2020 | $84,000 | -33.3% | 5,270 | 0.0% | 0.02% | -21.7% |
| Q4 2019 | $126,000 | +35.5% | 5,270 | 0.0% | 0.02% | +27.8% |
| Q3 2019 | $93,000 | -31.1% | 5,270 | 0.0% | 0.02% | -25.0% |
| Q2 2019 | $135,000 | – | 5,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |